The FCS Foundation is now The Foundation for Triglyceride Disorders 💙 Same mission. Bigger reach — FCS, MCS, sHTG & TiP. ow.ly/1Mha50ZaAi8
@Amarincorp @ArrowheadPharma @ionispharma @advcardiohealth @ASPCardio @nationallipid @NatTgAlliance @NatPancFdn @TheAACE @HeartNurses
The Foundation for Triglyceride Disorders retweeted
See this Instagram post by @tgdisorders instagram.com/p/DeKiiATDPcb/…
Multifactorial Chylomicronemia Syndrome (MCS) is a disorder in which a combination of genetic predisposition and secondary factors leads to elevated triglyceride levels.
Learn more: ow.ly/48MO50ZV9oN
#MCS #TGDisorders #Triglycerides
The 3rd Annual FCS Summit brought our amazing FCS community together in Milwaukee for learning, laughter, and shared experiences.
From inspiring presentations to meaningful conversations, this Summit reminded us how strong we are when we come together.
#LivingWithFCS
FCS is a disorder in which the body cannot properly break down triglycerides. The Foundation for Triglyceride Disorders helps connect patients with caregivers and clinicians to provide education, resources, and community.
ow.ly/zCH450ZV97f
#FCS #TGDisorders #livingwithFCS
Have you experienced pancreatitis due to sHTG? @ArrowheadPharma wants your voice on its new Lived Experience Council! If you're 18+, U.S.-based, and English-speaking, email patientadvocacy@arrowheadpharma.com to learn more.
đź”— ow.ly/HqX550ZWjoN
#sHTG #PatientVoice
What an incredible weekend at the FCS Summit in Milwaukee! đź’™
We learned, shared, connected, and strengthened a community united by a shared mission: improving the lives of those living with FCS. Thank you to everyone who made it to the summit!
#LivingWithFCS #TGDisorders
Dennis knows exactly what he's looking forward to at the 2026 #FCS Foundation Patient & Caregiver Summit: seeing familiar faces and getting information and resources built specifically for the FCS community.
If you're living with FCS, this one's for you. survey.alchemer.com/s3/88137…
The Foundation for Triglyceride Disorders retweeted
Breaking News: At the European Society of Cardiology Congress (ESC), we presented Phase 3 SHASTA-3 & SHASTA-4 data demonstrating our investigational siRNA therapy reduced acute pancreatitis events in patients with severe hypertriglyceridemia.
Learn more: arrowheadpharma.com/en-us/ne…
The Foundation for Triglyceride Disorders retweeted
ESC Congress 2026 begins tomorrow! Looking forward to the scientific discussions ahead.
bit.ly/4qF9DoJ
#Cardiology #Science #ESCCongress
The Foundation for Triglyceride Disorders retweeted
New science builds stronger understanding.
Proud to share additional research at #ESCCongress 2026 as we continue advancing cardiovascular science.
Learn more: bit.ly/4gEcppR
#Cardiovascular #Research
The Foundation for Triglyceride Disorders retweeted
Learn more about new data presented at #ESCCongress from our open-label extension study of our treatment for severe hypertriglyceridemia (#sHTG): bit.ly/3SgSwwZ
The Foundation for Triglyceride Disorders retweeted
Dr. Matthew Budoff (UCLA) @BudoffMd explains why triglycerides — not LDL — may be the hidden driver of residual heart risk. 1 in 3 Americans have elevated triglycerides, and the new 2026 ACC-AHA guidelines now recognize them as a treatable risk marker.
This educational initiative is supported by an unrestricted educational grant from @Amarincorp
#Cardiology #Triglycerides #HeartHealth
The Foundation for Triglyceride Disorders retweeted
🎉 Join Us at #ASPC2026!
The National Triglyceride Alliance invites you to our reception at this year's @ASPCardio Congress on CVD Prevention!
đź“… Friday, July 31, 2026
🕖 7:15 – 8:15 PM
📍 Salon & Patio, The Phoenician, Scottsdale, AZ
Connect with clinicians, researchers, and advocates working to make triglyceride management a core part of cardiovascular care. Meet the NTA team, discover our latest educational resources, and network with colleagues at the forefront of CVD prevention.
🥂 Appetizers & refreshments served
👥 All ASPC 2026 attendees welcome — bring a colleague!
RSVP optional. We can't wait to see you there! đź’™
nationaltriglyceridealliance…
@mmillermd1 @SethJBaumMD @EliotBrinton @lipiddoc @ArchnaBajajMD @drmaggarwal @nationallipid @foundationofnla @NatPancFdn @TGDisorders @TheAACE @HeartNurses @ArrowheadPharma @Amarincorp
#CVDPrevention #Triglycerides #Cardiology
The Foundation for Triglyceride Disorders retweeted
Our newest educational module: "TG Therapies Old & New and Upcoming Clinical Trials" covers the full therapeutic landscape:
• Why traditional TG-lowering therapies fell short on cardiovascular outcomes despite lipid improvements
• The role of remnant lipoproteins and ApoC-III–mediated pathways in residual risk
• Clinical trial data on newer agents — and what's coming next
• A phenotype-driven approach to matching therapy to the right patient
Builds directly on the 2026 ACC/AHA dyslipidemia guidelines.
🎬 Watch free at nationaltriglyceridealliance…
#Lipidology #Cardiology #Hypertriglyceridemia #CardiovascularRisk #Dyslipidemia
@mmillermd1 @SethJBaumMD @EliotBrinton @lipiddoc @ArchnaBajajMD @drmaggarwal @nationallipid @foundationofnla @ASPCardio @NatPancFdn @TGDisorders @TheAACE @HeartNurses @ArrowheadPharma @Amarincorp
The Foundation for Triglyceride Disorders retweeted
BREAKING NEWS: We received U.S. FDA approval for a new indication of TRYNGOLZA® (olezarsen), a historic advance that reflects the strength of our innovative science. Read more: ir.ionis.com/news-releases/n…
"Having a community of people who understand the invisible challenges — that has been the greatest point of hope and healing." 💙
Shanna | Living with FCS
You don't have to navigate a triglyceride disorder alone.
đź”— tgdisorders.com
#TriglyceridDisorders #FCS
The Foundation for Triglyceride Disorders retweeted
Check out Module 4 to update your knowledge: nationaltriglyceridealliance…
@SethJBaumMD @EliotBrinton @mmillermd1 @lipiddoc @ArchnaBajajMD @drmaggarwal @nationallipid @foundationofnla @ASPCardio @NatPancFdn @TGDisorders @TheAACE @HeartNurses @ionispharma @ArrowheadPharma @Amarincorp
#Triglycerides #Hypertriglyceridemia #FCS
The Foundation for Triglyceride Disorders retweeted
đź§ #TrigTriviaTuesday
Familial Chylomicronemia Syndrome (FCS) is caused by a deficiency in which enzyme?
Drop your answer below 👇 — reveal coming in the reply!
0%HMG-CoA Reductase
100%Lipoprotein Lipase (LPL)
0%CETP
0%Hepatic Lipase
6 votes • Final results The Foundation for Triglyceride Disorders retweeted
Congratulations on 10 years of progress! We are excited for the next chapter @TGDisorders đź’™
Today, celebrating 10 years of progress, the FCS Foundation officially becomes The Foundation for Triglyceride Disorders 🎉 Same mission. Bigger reach — FCS, MCS, sHTG, TiP & more. No one should navigate this alone.
tgdisorders.com/
#TriglyceridDisorders #FCSFoundation






















